Serial 79223777
Live / Registered — Cancelled — Section 71 (as of 02 May 2025)
What this means for you
Registered since 16 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79223777
- Registration number
- 5582931
- Mark type
- Design / logo
- Filed
- 30 Mar 2017
- Published for opposition
- 01 May 2018
- Registered
- 16 Oct 2018
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of brain, mental and nervous system disorders, vertigo, cardiovascular issues, strokes, neurodegenerative diseases, infections, atherosclerosis, attention deficit disorder, hyperpiesis, neuroticism, psychosomatic diseases, stress disorders, asthenic syndrome, neurotoxicosis and obesity; veterinary preparations for the treatment of neuroticism and stress disorders; pharmaceuticals and veterinary preparations for use in the treatment of diabetes and complications from diabetes, insulin resistance, inflammation and inflammatory diseases, respiratory and infectious diseases, nasal congestion, coughs, fever, colds, flu, immunological problems, fungal infections, viral infections, herpes, chicken pox, mononucleosis, hemorrhagic fever, encephalitis, bacterial infections, pseudotuberculosis, whooping cough, yersiniosis and pneumonia; antibacterial preparations; antihistamines; pharmaceutical preparations for the treatment of AIDS and HIV infection; psychotropics; pharmaceutical preparations for the treatment of erectile dysfunction, benign prostatic hyperplasia, prostatitis, dysuric disorders, and menopause; pharmaceutical preparations for improving digestion and reducing flatulence; pharmaceutical preparations for the treatment of irritable bowel syndrome and gastrointestinal disorders; anticonvulsants; antianxiety preparations; cough treatment preparations; pharmaceutical preparations for the treatment of respiratory tract infection; pharmaceutical preparations for the treatment of rheumatic arthritis, osteoarthrosis, arthropathy and ulcerative colitis; pharmaceutical antihypoxic preparations for use in the treatment of respiratory, pulmonary and circulatory diseases; antioxidants; pharmaceutical vasoprotective preparations for use in the treatment of blood disorders, hemorrhoids, varicose veins and vascular diseases; pharmaceutical antihyperglycemic preparations for use in the treatment of elevated levels of glucose and glycated hemoglobin in the blood; pharmaceutical preparations for the treatment of alcohol and nicotine addiction; homeopathic supplements; pharmaceutical preparations for the treatment of central nervous system disorders; pharmaceutical preparations for the prevention and treatment of mental and neurological disorders and conditions; psychoactive pharmaceutical preparations; anxiolytics, nootropics, psycholeptics, sedatives, antidepressants and neuroleptics; pharmaceutical preparations which stimulate the parasympathetic nervous system, enhance memory function, and prevent and alleviate stress and attention deficit disorder; lactose for pharmaceutical purposes; capsules sold empty for pharmaceuticals; vitamin preparations; medical preparations for slimming purposes; nerve calming preparations for medical purposes; appetite suppressant pills
Owner
- Mapix S.à.r.l, LU
- Mapix S.à.r.l, LU
- Mapix S.à.r.l, LU
Prosecution history
- 02 Jan 2026 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 02 May 2025 — CANCELLED SECTION 71
- 16 Oct 2023 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 15 Feb 2019 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 29 Jan 2019 — FINAL DISPOSITION NOTICE SENT TO IB
- 29 Jan 2019 — FINAL DISPOSITION PROCESSED
- 16 Jan 2019 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 16 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 09 Sept 2018 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 01 Jun 2018 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 04 May 2018 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 01 May 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 May 2018 — PUBLISHED FOR OPPOSITION
- 11 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER